IMS Health Holdings Inc

IMS Health — Q2 2005 Earnings Presentation

12 slides from IMS Health's earnings presentation, Jul 20, 2005

  1. Slide 1: Q2 2005 Earnings Conference Call Highlights

    Q2 2005 Earnings Conference Call Highlights

  2. Slide 2: Safe Harbor

    Safe Harbor About IMS Health Incorporated IMS Health Incorporated ("IMS") provides sales management and market research information services to the pharmaceutical and healthcare industries worldwide. IMS provides information services covering more than 100 countries and maintains offices in 76 count

  3. Slide 3: Additional Information and Where to Find It

    Additional Information and Where to Find It This document may be deemed to be solicitation material in respect of the proposed merger of IMS and VNU. In connection with the proposed transaction, VNU and IMS will file a registration statement on Form F-4, including the preliminary joint proxy stateme

  4. Slide 4: All financials shown are on an adjusted basis

    All financials shown are on an "adjusted basis": Adjusted results are those used by management for the purposes of global business decision-making, including developing budgets and managing expenditures. Adjusted results exclude certain U.S. GAAP measures to the extent that management believes exclu

  5. Slide 5: Q2 2005 Financial Highlights

    Q2 2005 Financial Highlights Revenue $433M Reported Growth 14% Adjusted Net Income $78M Growth 12% Adjusted EPS $0.34 Growth 17% Adjusted Operating Income $111M Growth 8%

  6. Slide 6: Business Lines: First Half Revenue Growth

    Business Lines: First Half Revenue Growth Offerings Line View - Consulting & Services Embedded in Business Lines

  7. Slide 7: Q2 2005 Reported Revenue Growth

    Q2 2005 Reported Revenue Growth Americas + 10% Focus on execution driving an accelerating performance Europe + 19% Asia Pacific + 14%

  8. Slide 8: Q2 2005 Adjusted Earnings

    Actual Year to Year Year to Year C-D Revenue 433.3 14% 12% Op Income 110.7 8% 7% Net Income 77.8 12% EPS $0.34 17% Q2 2005 Adjusted Earnings ($ millions, except per share) Repurchased 2.3 million shares in Q2 2005

  9. Slide 9: Sustainable Financial Model

    Sustainable Financial Model Strategic Goals 8 Quarter Performance* CD Revenue Growth 8 - 13% 9% Adjusted EPS Growth ? Revenue Growth 13% ROIC >30% ? 30%** Free Cash Flow Conversion >85% Net Earnings >95% Net Earnings *Trailing 8 quarter performance ** Based on 2002 - 2004 annual results

  10. Slide 10: Statement on Guidance

    Statement on Guidance IMS expects SEC-reported third quarter and full-year diluted earnings per share ("EPS") to differ from adjusted diluted EPS. Items that could cause third quarter and full-year 2005 SEC- reported diluted EPS to differ from adjusted diluted EPS include, but are not limited to, ad

  11. Slide 11: 2005 Guidance

    2005 Guidance Full Year 2005 Guidance CD Revenue Growth 10% - 12% Adjusted EPS $1.29 - $1.35 Free Cash Flow $250 - $295m Share Repurchase 6.2M shares through 1H No additional repurchases planned Q3 2005 Guidance CD Revenue Growth 11 - 13% Adjusted EPS $0.30 - $0.33

  12. Slide 12: IMS Intelligence. Applied.

    i eeecoeeee ims e | m S INTELLIGENCE. APPLIED.

IMS Health — Q2 2005 Earnings Presentation on 6ix